Literature DB >> 148880

Pathology of the Lens in Down's syndrome.

R M Robb, A Marchevsky.   

Abstract

A pathological study of the lenses of 21 patients with Down's syndrome disclosed no distinctive abnormalities of the lens capsule, as had been reported previously. Five patients, 15 years of age or older, had focal cortical changes consistent with the characteristic flake-like opacities seen in patients with Down's syndrome after the first decade of life. Three patients with more extensive, visually significant lens opacities showed nonspecific cataractous changes. No abnormalities other than pathological artifacts were seen in the lenses of patients younger than 15 years of age.

Entities:  

Mesh:

Year:  1978        PMID: 148880     DOI: 10.1001/archopht.1978.03910050559014

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Authors:  Juliet A Moncaster; Roberto Pineda; Robert D Moir; Suqian Lu; Mark A Burton; Joy G Ghosh; Maria Ericsson; Stephanie J Soscia; Anca Mocofanescu; Rebecca D Folkerth; Richard M Robb; Jer R Kuszak; John I Clark; Rudolph E Tanzi; David G Hunter; Lee E Goldstein
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

3.  Lens artifacts in human fetal eyes - the challenge of interpreting the histomorphology of human fetal lenses.

Authors:  Martina C Herwig; Annette M Müller; Ute Klarmann-Schulz; Frank G Holz; Karin U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-06       Impact factor: 3.117

4.  β-amyloid expression in age-related cataract lens epithelia and the effect of β-amyloid on oxidative damage in human lens epithelial cells.

Authors:  Jie Xu; Dan Li; Tianyu Zheng; Yi Lu
Journal:  Mol Vis       Date:  2017-12-25       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.